| Medical and Health Sciences | Lifetime | 31 | US 15 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 81 | US 32 | 99.98 |
| Cardiology and Cardiovascular Medicine | Lifetime | 10 | US 7 | 99.99 |
| General Health Professions | Lifetime | 144 | US 69 | 99.82 |
| Pediatrics, Perinatology and Child Health | Lifetime | 55 | US 25 | 99.82 |
| Complementary and Alternative Medicine | Lifetime | 106 | US 48 | 99.52 |
| Demography | Lifetime | 181 | US 102 | 99.33 |
| Gender Studies | Lifetime | 168 | US 110 | 99.13 |
| Public, Environmental and Occupational Health | Lifetime | 725 | US 373 | 98.97 |
| Pulmonary and Respiratory Medicine | Lifetime | 716 | US 376 | 98.93 |
| Safety Research | Lifetime | 312 | US 177 | 98.25 |
| Hematology | Lifetime | 599 | US 305 | 95.47 |
| Nephrology | Lifetime | 795 | US 369 | 87.73 |
| Geriatrics and Gerontology | Lifetime | 524 | US 207 | 75.89 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 16 | US 9 | 99.92 |
| Hematology | 2021-2025 | 55 | US 31 | 98.78 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 248 | US 90 | 95.14 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 221 | US 93 | 96.02 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 518 | US 179 | 94.31 |
| Cardiac pacing and defibrillation studies | Lifetime | 1 | US 1 | 99.99 |
| Cardiovascular Function and Risk Factors | Lifetime | 6 | US 6 | 99.99 |
| Heart Failure Treatment and Management | Lifetime | 3 | US 3 | 99.99 |
| Demographic Trends and Gender Preferences | Lifetime | 1 | US 1 | 99.77 |
| Global Maternal and Child Health | Lifetime | 7 | US 3 | 99.95 |
| Reproductive Health and Contraception | Lifetime | 4 | US 2 | 99.65 |
| Adolescent Sexual and Reproductive Health | Lifetime | 15 | US 11 | 99.76 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 34 | US 19 | 99.83 |
| Poverty, Education, and Child Welfare | Lifetime | 9 | US 8 | 99.74 |
| Potassium and Related Disorders | Lifetime | 7 | US 6 | 99.81 |
| Cardiac Arrhythmias and Treatments | Lifetime | 88 | US 45 | 99.67 |
| Medication Adherence and Compliance | Lifetime | 20 | US 13 | 99.31 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 104 | US 50 | 99.66 |
| Erythropoietin and Anemia Treatment | Lifetime | 19 | US 10 | 99.42 |
| Blood Pressure and Hypertension Studies | Lifetime | 98 | US 44 | 99.60 |
| Cardiovascular and exercise physiology | Lifetime | 78 | US 36 | 99.48 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 273 | US 132 | 99.17 |
| Iron Metabolism and Disorders | Lifetime | 135 | US 62 | 98.77 |
| Cardiac Health and Mental Health | Lifetime | 120 | US 73 | 98.80 |
| HIV/AIDS Impact and Responses | Lifetime | 41 | US 13 | 98.61 |
| Mechanical Circulatory Support Devices | Lifetime | 252 | US 153 | 98.80 |
| Cardiac Imaging and Diagnostics | Lifetime | 567 | US 289 | 99.10 |
| Cardiomyopathy and Myosin Studies | Lifetime | 238 | US 126 | 98.58 |
| Hemodynamic Monitoring and Therapy | Lifetime | 239 | US 92 | 98.43 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 774 | US 386 | 98.50 |
| Electrolyte and hormonal disorders | Lifetime | 164 | US 80 | 98.10 |
| Cardiac Valve Diseases and Treatments | Lifetime | 621 | US 306 | 98.78 |
| Diabetes Treatment and Management | Lifetime | 467 | US 179 | 98.27 |
| Cardiac Structural Anomalies and Repair | Lifetime | 589 | US 354 | 98.34 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 579 | US 285 | 97.36 |
| Lipoproteins and Cardiovascular Health | Lifetime | 652 | US 298 | 97.43 |
| Heart rate and cardiovascular health | Lifetime | 42 | US 15 | 97.12 |
| Sex work and related issues | Lifetime | 297 | US 171 | 96.57 |
| Acute Myocardial Infarction Research | Lifetime | 943 | US 381 | 97.29 |
| Chronic Disease Management Strategies | Lifetime | 654 | US 222 | 96.39 |
| Hemoglobinopathies and Related Disorders | Lifetime | 906 | US 461 | 96.18 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 779 | US 277 | 96.77 |
| Insurance, Mortality, Demography, Risk Management | Lifetime | 207 | US 84 | 95.43 |
| Global Health Care Issues | Lifetime | 842 | US 342 | 94.88 |
| GDF15 and Related Biomarkers | Lifetime | 139 | US 50 | 92.47 |
| Gender, Labor, and Family Dynamics | Lifetime | 757 | US 469 | 93.02 |
| Artificial Intelligence in Healthcare | Lifetime | 818 | US 111 | 87.32 |
| Aortic Thrombus and Embolism | Lifetime | 426 | US 170 | 76.50 |
| Iron Metabolism and Disorders | 2021-2025 | 1 | US 1 | 99.76 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 26 | US 13 | 99.84 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 18 | US 7 | 99.68 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 3 | US 2 | 99.72 |
| Heart Failure Treatment and Management | 2021-2025 | 24 | US 14 | 99.82 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 29 | US 15 | 98.47 |
| Diabetes Treatment and Management | 2021-2025 | 213 | US 82 | 97.62 |
| Global Maternal and Child Health | 2021-2025 | 419 | US 73 | 95.13 |
| Potassium and Related Disorders | 2021-2025 | 50 | US 25 | 95.82 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 674 | US 173 | 95.49 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 904 | US 247 | 94.53 |
| Electrolyte and hormonal disorders | 2021-2025 | 96 | US 31 | 90.66 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 892 | US 238 | 93.45 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 629 | US 222 | 91.40 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 401 | US 82 | 91.43 |
| GDF15 and Related Biomarkers | 2021-2025 | 93 | US 24 | 83.65 |
| Chronic Disease Management Strategies | 2021-2025 | 767 | US 141 | 85.67 |
| Reproductive Health and Contraception | 2021-2025 | 301 | US 194 | 86.45 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 314 | US 83 | 79.33 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 987 | US 325 | 82.85 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 909 | US 203 | 79.27 |
| Medication Adherence and Compliance | 2021-2025 | 887 | US 297 | 69.68 |
| Renal function and acid-base balance | 2021-2025 | 488 | US 147 | 63.54 |
